Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer

OncoImmunology

Volumn 5, Issue 3, 2016, Pages

  Park, J H ^a   McMillan, D C ^a   Edwards, J ^a   Horgan, P G ^a   Roxburgh, C S D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Colorectal cancer; tumor inflammatory cell infiltrate; tumor microenvironment; tumor stroma

Indexed keywords

C REACTIVE PROTEIN; CD3 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; ASSESSMENT OF HUMANS; CANCER INFILTRATION; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CELL DENSITY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSCORE; INFLAMMATION; KLINTRUP MAKINEN SCORE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; STROMA CELL; TUMOR MICROENVIRONMENT; TUMOR STROMA PERCENTAGE;

EID: 84961618598     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1098801     Document Type: Article

References (29)

1. J.Ferlay, E.Steliarova-Foucher, J.Lortet-Tieulent, S.Rosso, J.W.Coebergh, H.Comber, D.Forman, F.Bray. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49:1374-403; PMID:23485231; http://dx.doi.org/10.1016/j.ejca.2012.12.027
2. Fleming ID, American Joint Committee on Cancer, American Cancer Society, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott- Raven; 1997.
3. C.S.Roxburgh, D.C.McMillan. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev 2012; 38:451-66; PMID:21945823; http://dx.doi.org/10.1016/j.ctrv.2011.09.001
4. Z.Mei, Y.Liu, C.Liu, A.Cui, Z.Liang, G.Wang, H.Peng, L.Cui, C.Li. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis. Br J Cancer 2014; 110:1595-605; PMID:24504370; http://dx.doi.org/10.1038/bjc.2014.46
5. K.Klintrup, J.M.Makinen, S.Kauppila, P.O.Vare, J.Melkko, H.Tuominen, K.Tuppurainen, J.Mäkelä, T.J.Karttunen, M.J.Mäkinen. Inflammation and prognosis in colorectal cancer. Eur J Cancer 2005; 41:2645-54; PMID:16239109; http://dx.doi.org/10.1016/j.ejca.2005.07.017
6. C.S.Roxburgh, J.M.Salmond, P.G.Horgan, K.A.Oien, D.C.McMillan. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 2009; 249:788-93; PMID:19387324; http://dx.doi.org/10.1097/SLA.0b013e3181a3e738
7. J.Galon, A.Costes, F.Sanchez-Cabo, A.Kirilovsky, B.Mlecnik, C.Lagorce-Pages, M.Tosolini, M.Camus, A.Berger, P.Wind et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
8. J.Galon, B.Mlecnik, G.Bindea, H.K.Angell, A.Berger, C.Lagorce, A.Lugli, I.Zlobec, A.Hartmann, C.Bifulco et al. Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours. J Pathol 2014; 232:199-209; PMID:24122236; http://dx.doi.org/10.1002/path.4287
9. B.Mlecnik, M.Tosolini, A.Kirilovsky, A.Berger, G.Bindea, T.Meatchi, P.Bruneval, Z.Trajanoski, W.H.Fridman, F.Pagès et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 2011; 29:610-8; PMID:21245428; http://dx.doi.org/10.1200/JCO.2010.30.5425
10. M.G.Anitei, G.Zeitoun, B.Mlecnik, F.Marliot, N.Haicheur, A.M.Todosi, A.Kirilovsky, C.Lagorce, G.Bindea, D.Ferariu et al. Prognostic and predictive values of the immunoscore in patients with rectal cancer. Clin Cancer Res 2014; 20:1891-9; PMID:24691640; http://dx.doi.org/10.1158/1078-0432.CCR-13-2830
11. C.Isella, A.Terrasi, S.E.Bellomo, C.Petti, G.Galatola, A.Muratore, A.Mellano, R.Senetta, A.Cassenti, C.Sonetto et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet 2015; 47:312-9; PMID:25706627; http://dx.doi.org/10.1038/ng.3224
12. W.E.Mesker, J.M.Junggeburt, K.Szuhai, P.de Heer, H.Morreau, H.J.Tanke, R.A.Tollenaar. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol 2007; 29:387-98; PMID:17726261; http://dx.doi.org/10.1155/2007/175276
13. J.H.Park, C.H.Richards, D.C.McMillan, P.G.Horgan, C.S.Roxburgh. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Ann Oncol 2014; 25:644-51; PMID:24458470; http://dx.doi.org/10.1093/annonc/mdt593
14. T.J.Dekker, C.J.van de Velde, G.W.van Pelt, J.R.Kroep, J.P.Julien, V.T.Smit, R.A.Tollenaar, W.E.Mesker. Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat 2013; 139:371-9; PMID:23709090; http://dx.doi.org/10.1007/s10549-013-2571-5
15. E.F.Courrech Staal, M.W.Wouters, J.W.van Sandick, M.M.Takkenberg, V.T.Smit, J.M.Junggeburt, J.M.Spitzer-Naaykens, T.Karsten, H.H.Hartgrink, W.E.Mesker et al. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy? Eur J Cancer 2010; 46:720-8; PMID:20044247; http://dx.doi.org/10.1016/j.ejca.2009.12.006
16. A.Huijbers, R.A.Tollenaar, G.W.v Pelt, E.C.Zeestraten, S.Dutton, C.C.McConkey, E.Domingo, V.T.Smit, R.Midgley, B.F.Warren et al. The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 2013; 24:179-85; PMID:22865778; http://dx.doi.org/10.1093/annonc/mds246
17. J.H.Park, D.C.McMillan, A.G.Powell, C.H.Richards, P.G.Horgan, J.Edwards, C.S.Roxburgh. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer. Clin Cancer Res 2015; 21:882-8; PMID:25473000; http://dx.doi.org/10.1158/1078-0432.CCR-14-1686
18. Park JH, Watt DG, Roxburgh CS, Horgan PG, McMillan DC. Colorec- tal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host. Ann Surg 2015;263:326-36; PMID:25575264; http://dx.doi.org/10.1097/SLA.0000000000001122
19. C.H.Richards, C.S.Roxburgh, A.G.Powell, A.K.Foulis, P.G.Horgan, D.C.McMillan. The clinical utility of the local inflammatory response in colorectal cancer. Eur J Cancer 2014; 50:309-19; PMID:24103145; http://dx.doi.org/10.1016/j.ejca.2013.09.008
20. J.P.Vayrynen, A.Tuomisto, K.Klintrup, J.Makela, T.J.Karttunen, M.J.Makinen. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer 2013; 109:1839-47; PMID:24008661; http://dx.doi.org/10.1038/bjc.2013.508
21. C.H.Richards, K.M.Flegg, C.S.D.Roxburgh, J.J.Going, Z.Mohammed, P.G.Horgan, D.C.McMillan. The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. Br J Cancer 2012; 106:2010-5; PMID:22596238; http://dx.doi.org/10.1038/bjc.2012.211
22. M.R.Galdiero, C.Garlanda, S.Jaillon, G.Marone, A.Mantovani. Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol 2013; 228:1404-12; PMID:23065796; http://dx.doi.org/10.1002/jcp.24260
23. N.Hartmann, N.A.Giese, T.Giese, I.Poschke, R.Offringa, J.Werner, E.Ryschich. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. Clin Cancer Res 2014; 20:3422-33; PMID:24763614; http://dx.doi.org/10.1158/1078-0432.CCR-13-2972
24. A.Chrysanthopoulou, I.Mitroulis, E.Apostolidou, S.Arelaki, D.Mikroulis, T.Konstantinidis, E.Sivridis, M.Koffa, A.Giatromanolaki, D.T.Boumpas et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol 2014; 233:294-307; PMID:24740698; http://dx.doi.org/10.1002/path.4359
25. J.H.Park, C.S.Roxburgh, D.C.McMillan. Comment on ‘Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis’. Br J Cancer 2014; 111:2372; PMID:25349973; http://dx.doi.org/10.1038/bjc.2014.296
26. N.Turner, H.L.Wong, A.Templeton, S.Tripathy, T.W.Rogers, M.Croxford, I.Jones, M.Sinnathamby, J.Desai, J.Tie et al. Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria. Int J Cancer 2016; 138:671-8; PMID:26270488; http://dx.doi.org/10.1002/ijc.29805
27. Quasar Collaborative G, R.Gray, J.Barnwell, C.McConkey, R.K.Hills, N.S.Williams, D.J.Kerr. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370:2020-9; PMID:18083404; http://dx.doi.org/10.1016/S0140-6736(07)61866-2
28. R.Forrest, G.J.Guthrie, C.Orange, P.G.Horgan, D.C.mcmillan, C.S.Roxburgh. Comparison of visual and automated assessment of tumour inflammatory infiltrates in patients with colorectal cancer. Eur J Cancer 2014; 50:544-52; PMID:24332571; http://dx.doi.org/10.1016/j.ejca.2013.11.003
29. L.De Smedt, J.Lemahieu, S.Palmans, O.Govaere, T.Tousseyn, E.Van Cutsem, H.Prenen, S.Tejpar, M.Spaepen, G.Matthijs et al. Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis. Br J Cancer 2015; 113(3):500-9; PMID:26068398; http://dx.doi.org/10.1038/bjc.2015.213